PipeHawk PLC Grant of options

RNS Number : 8386Q

PipeHawk PLC

20 December 2024

 

20 December 2024

PipeHawk plc

("PipeHawk", "Company" or the "Group")

 

Grant of options

 

The board of directors of PipeHawk have approved the grant of 1,100,000 options (the "Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") to certain senior employees of the Group. The Options were granted pursuant to the Group's existing share option scheme ("Option Scheme").

 

The Options have an exercise price of 2.35 pence, being the closing mid-market price of an Ordinary Share on 19 December 2024, the day prior to grant. The Options are exercisable from 20 December 2027 to 20 December 2034, conditional upon the share price of an Ordinary Share being at least 5 pence for a period of 30 consecutive business days prior to exercise, and the Option holder being an employee of the Group or one of its subsidiaries.

 

Following the grant of the Options, the total number of Ordinary Shares under option is 3,190,000, representing approximately 8.78% of the Company's current issued ordinary share capital.    

 

-Ends-

 

Enquiries:

 

PipeHawk plc Gordon Watt (Chairman)	Tel. No. 01252 338 959
Allenby Capital Limited (Nomad and Broker)	Tel. No. 020 3328 5656

David Hart / Vivek Bhardwaj

 

For further information on the Company and its subsidiaries, please visit:  www.pipehawk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDGPGGAPUPCGMB